Current and future use of the mannitol bronchial challenge in everyday clinical practice

Clinical Respiratory Journal

Volumn 3, Issue 4, 2009, Pages 189-197

  Porsbjerg, Celeste ^a   Backer, Vibeke ^a   Joos, Guy ^b   Kerstjens, Huib Adrianus Marie ^c   Rodriguez Roisin, Roberto ^d  

^a BISPEBJERG HOSPITAL   (Denmark)

^b GHENT UNIVERSITY HOSPITAL   (Belgium)

^c UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^d HOSPITAL CLÍNIC   (Spain)

Author keywords

Airway; Asthma; Bronchial; Challenge; Hyperresponsiveness; Mannitol

Indexed keywords

ADENOSINE PHOSPHATE; ANTIINFLAMMATORY AGENT; BRONCHOCONSTRICTING AGENT; CORTICOSTEROID; MANNITOL; METHACHOLINE;

ASTHMA; BRONCHOSPASM; CLINICAL PRACTICE; COUGHING; DIAGNOSTIC TEST; DISEASE ASSOCIATION; DRUG EFFICACY; DRUG RESPONSE; DRUG TOLERABILITY; HUMAN; LUNG DISEASE; LUNG FUNCTION; MEDICAL PRACTICE; MEDICAL SOCIETY; PNEUMONIA; PREDICTION; PRIORITY JOURNAL; RESPIRATORY TRACT DISEASE; REVIEW; SENSITIVITY AND SPECIFICITY;

EID: 70349244870     PISSN: 17526981     EISSN: 1752699X     Source Type: Journal    
DOI: 10.1111/j.1752-699X.2009.00161.x     Document Type: Review

References (39)

1. Brannan JD, Koskela H, Anderson SD. Monitoring asthma therapy using indirect bronchial challenge tests. Clin Respir J. 2007 1 : 3 15.
2. Currie GP, Haggart K, Brannan JD, Lee DKC, Anderson SD, Lipton BJ. Relationship between airway hyperresponsiveness to mannitol and adenosine monophosphate. Allergy. 2003 58 : 762 766. (Pubitemid 36920466)
3. Global Initiative for Asthma. Global strategy for asthma management and prevention. Updated 2008. Available from URL: http://www.ginasthma.org [accessed 14 April 2009 RO, Casaburi R, Coates AL, et al. Guidelines for methacholine and exercise challenge testing - 1999. Am J Respir Crit Care Med. 2000 161 : 309 329.
4. American Thoracic Society. Guidelines for methacholine and exercise challenge testing - 1999. Am J Respir Crit Care Med. 2000 161 : 309 329.
5. Joos GF, O'Connor B, Anderson SD, et al. on behalf of the ERS Task Force Indirect airway challenges. Eur Respir J. 2003 21 : 1050 1068.
6. Sont JK, Willems LN, Bel EH, van Krieken JH, Vandenbroucke JP, Sterk PJ. Clinical control and histopathologic outcome of asthma when using airway hyperresponsiveness as an additional guide to long-term treatment. The AMPUL Study Group. Am J Respir Crit Care Med. 1999 159 : 1043 1051.
7. Menzies D, Nair A, Lipworth BJ. Non-invasive measurement of airway inflammation in asthma. J Asthma. 2006 43 : 407 415.
8. Smith AD, Cowan JO, Filsell S, McLachlan C, Monti-Sheehan G, Jackson P, Taylor DR. Diagnosing asthma: comparisons between exhaled nitric oxide measurements and conventional tests. Am J Respir Crit Care Med. 2004 169 : 473 478.
9. Currie GP, Jackson CM, Lipworth BJ. Does bronchial hyperresponsiveness in asthma matter? J Asthma. 2004 41 : 247 258.
10. Van Schoor J, Joos GF, Pauwels RA. Indirect bronchial hyperresponsiveness in asthma: mechanisms, pharmacology and implications for clinical research. Eur Resp J. 2000 16 : 514 533.
11. Anderson S, Daviskas E. The mechanism of exercise induced asthma. J Allergy Clin Immunol. 2000 106 : 453 459.
12. Brannan JD, Gulliksson M, Anderson SD, Chew N, Kumlin M. Evidence of mast cell activation and leukotriene release after mannitol inhalation. Eur Resp J. 2003 22 : 1 6.
13. Polosa R. Adenosine receptor subtypes: their relevance to adenosine-mediated responses in asthma and chronic obstructive pulmonary disease. Eur Respir J. 2002 20 : 488 496.
14. 20 methacholine. Am J Respir Crit Care Med. 2001 163 : 1546 1550.
15. 20 of adenosine 5 monophosphate is more closely associated with airway inflammation in asthma than PC20 methacholine. Am J Respir Crit Care Med. 2001 164 : 1127 1132. (Pubitemid 33052238)
16. Porsbjerg C, Brannan JD, Anderson SD, Backer V. Relationship between airway responsiveness to mannitol and to methacholine and markers of airway inflammation, peak flow variability and quality of life in asthma patients. Clin Exp Allergy. 2008 38 : 43 50.
17. Cockcroft DW. How best to measure airway responsiveness. Am J Respir Crit Care Med. 2001 163 : 1514 1515.
18. Backer V, Groth S, Dirksen A, Bach-Mortensen N, Hansen KK, Laursen EM, Wendelboe D. Sensitivity and specificity of the histamine challenge test for the diagnosis of asthma in an unselected sample of children and adolescents. Eur Respir J. 1991 4 : 1093 1100.
19. Crimi E, Spanevello A, Neri M, Ind PW, Rossi GA, Brusasco V. Dissociation between airway inflammation and airway hyperresponsiveness in allergic asthma. Am J Respir Crit Care Med. 1998 157 : 4 9. (Pubitemid 28071253)
20. Avital A, Springer C, Bar-Yishay E, Godfrey S. Adenosine, methacholine and exercise challenges in children with asthma or pediatric obstructive pulmonary disease. Thorax. 1995 50 : 511 516.
21. Gibson PG, Saltos N, Borgas T. Airway mast cells and eosinophils correlate with clinical severity and airway hyperresponsiveness in corticosteroid treated asthma. J Allergy Clin Immunol. 2000 105 : 752 759.
22. Woolcock AJ. What are the important questions in the treatment of asthma?. Clin Exp Allergy Rev. 2001 1 : 62 4.
23. Prosperini G, Rajakulasingam K, Cacciola RR, Spicuzza L, Rorke S, Holgate ST, Di Maria GU, Polosa R. Changes in sputum counts and airway hyperresponsiveness after budesonide: monitoring anti-inflammatory response on the basis of surrogate markers of airway inflammation. J Allergy Clin Immunol. 2002 110 : 855 861.
24. Anderson SD, Brannan J, Spring J, Spalding N, Rodwell LT, Chan K, Gonda I, Walsh A, Clark AR. A new method for bronchial-challenge testing in asthmatic subjects using a dry powder of mannitol. Am J Respir Crit Care Med. 1997 156 : 758 765.
25. Anderson SA, Brannan JD. Methods for 'indirect' challenge tests including exercise, eucapnic voluntary hyperpnea, and hypertonic aerosols. Clin Rev Allergy Immunol. 2003 24 : 27 54.
26. Anderson SD, Charlton B, Weiler JM, Nichols S, Spector SL, Pearlman DS. Comparison of mannitol and methacholine to predict exercise-induced bronchoconstriction and a clinical diagnosis of asthma. Respir Res. 2009 10 : 4 doi:10.1186/1465-9921-10-4.
27. Leuppi JD, Brannan JD, Anderson SA. Bronchial challenge tests: the rationale for using inhaled mannitol as a test for airway hyperresponsiveness. Swiss Med Wkly. 2002 132 : 151 158.
28. Brannan JD, Anderson SA, Perry CP, Freed-Martens R, Lassig AR, Charlton B, Aridol Study Group. The safety and efficacy of inhaled dry powder mannitol as a bronchial challenge test for airway hyperresponsiveness: a phase 3 comparison study with hypertonic (4.5%) saline. Resp Res. 2005 6 : 144.
29. Brannan JD, Koskela H, Anderson SD, Chew N. Responsiveness to mannitol in asthmatic subjects with exercise- and hyperventilation-induced asthma. Am J Respir Crit Care Med. 1998 158 : 1120 1126.
30. Munoz PA, Gómez FP, Manrique HA, Roca J, Barberà JA, Young IH, Anderson SD, Rodríguez-Roisin R. Pulmonary gas exchange response to exercise- and mannitol-induced bronchoconstriction in mild asthma. J Appl Physiol. 2008 105 : 1477 1485.
31. Holzer K, Anderson SD, Chan H-K, Douglass J. Mannitol as a challenge test to identify exercise-induced bronchoconstriction in elite athletes. Am J Respir Crit Care Med. 2003 167 : 534 547.
32. Porsbjerg C, Rasmussen L, Thomsen SF, Brannan JD, Anderson SD, Backer V. Response to mannitol in asymptomatic subjects with airway hyper-responsiveness to methacholine. Clin Exp Allergy. 2007 37 : 22 8.
33. Sverrild A, Porsbjerg C, Thomsen SF, Backer V. Diagnostic properties of inhaled mannitol in the diagnosis of asthma - a population study J Allergy Clin Immunol. 2009 doi:10.1016/j.jaci.2009.06.028.
34. Brannan JD, Koskela H, Anderson SD, Chan H-K. Budesonide reduces sensitivity and reactivity to inhaled mannitol in asthmatic subjects. Respirology. 2002 7 : 37 44.
35. Anderson SD, Wong R, Bennett M, Beckert L. Summary of knowledge and thinking about asthma and diving since 1993. Discussion paper, The Thoracic Society of Australia and New Zealand. Thorac Soc News. 2004 14 : 61 8.
36. Miedinger D, Miedinger D, Chhajed PN, Tamm M, Stolz D, Surber C, Leuppi JD. Diagnostic tests for asthma in firefighters. Chest. 2007 31 : 1760 1767.
37. International Olympic Committee, Medical and Scientific Department. Beta2 adrenoceptor agonists and the Olympic Games in Beijing. Available from URL: http://multimedia.olympic.org/pdf/en-report-1302.pdf [accessed 3 March 2009 PJ, Pedersen S, Busse WW. Efficacy and safety of inhaled corticosteroids. New developments. Am J Respir Crit Care Med. 1998 157 : S1 53.
38. Joos GF. Bronchial hyperresponsiveness. In : Kay AB, Bousquet J, Holt PG, Kaplan AP, editors. Allergy and Allergic Diseases, 2nd edn. West Sussex, UK, Blackwell Publishing, 2008 781 791.
39. Leuppi JD, Salome CM, Jenkins CR, et al. Predictive markers of asthma exacerbation during stepwise dose reduction of inhaled corticosteroids. Am J Respir Crit Care Med. 2001 163 (2 406 412.